Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020

SELL
$20.56 - $63.12 $39,598 - $121,569
-1,926 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$28.14 - $73.01 $44,151 - $114,552
1,569 Added 439.5%
1,926 $122,000
Q3 2019

Nov 07, 2019

SELL
$26.26 - $34.86 $24,474 - $32,489
-932 Reduced 72.3%
357 $10,000
Q2 2019

Aug 08, 2019

BUY
$17.43 - $28.82 $22,467 - $37,148
1,289 New
1,289 $34,000
Q2 2018

Jul 24, 2018

SELL
$6.37 - $14.02 $257,679 - $567,137
-40,452 Closed
0 $0
Q1 2018

Apr 12, 2018

SELL
$3.72 - $7.64 $116,108 - $238,459
-31,212 Reduced 43.55%
40,452 $291,000
Q4 2017

Jan 18, 2018

BUY
$3.14 - $4.5 $207,412 - $297,247
66,055 Added 1177.66%
71,664 $264,000
Q3 2017

Oct 13, 2017

BUY
$1.69 - $4.33 $9,479 - $24,286
5,609
5,609 $24,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.